Encompass Health Corporation
EHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,225,765 | $6,638,640 | $5,933,152 | $5,137,110 |
| - Cash | $85,400 | $69,100 | $21,800 | $54,800 |
| + Debt | $2,713,800 | $2,932,800 | $2,992,300 | $3,538,200 |
| Enterprise Value | $11,854,165 | $9,502,340 | $8,903,652 | $8,620,510 |
| Revenue | $5,373,200 | $4,801,200 | $4,348,600 | $4,014,900 |
| % Growth | 11.9% | 10.4% | 8.3% | – |
| Gross Profit | $2,233,200 | $1,982,800 | $1,753,200 | $1,703,400 |
| % Margin | 41.6% | 41.3% | 40.3% | 42.4% |
| EBITDA | $1,186,600 | $1,005,700 | $870,100 | $888,900 |
| % Margin | 22.1% | 20.9% | 20% | 22.1% |
| Net Income | $455,700 | $352,000 | $271,000 | $412,200 |
| % Margin | 8.5% | 7.3% | 6.2% | 10.3% |
| EPS Diluted | 4.46 | 3.47 | 2.7 | 4.11 |
| % Growth | 28.5% | 28.5% | -34.3% | – |
| Operating Cash Flow | $1,002,800 | $850,800 | $705,800 | $715,800 |
| Capital Expenditures | -$642,500 | -$583,100 | -$584,100 | -$551,200 |
| Free Cash Flow | $360,300 | $267,700 | $121,700 | $164,600 |